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Abstract Exposure to environmental mercury has
been proposed to play a part in autism. Mercury is
selectively taken up by the human locus ceruleus, a
region of the brain that has been implicated in autism. We
therefore looked for the presence of mercury in the locus
ceruleus of people who had autism, using the histochem-
ical technique of autometallography which can detect
nanogram amounts of mercury in tissues. In addition, we
sought evidence of damage to locus ceruleus neurons in
autism by immunostaining for hyperphosphorylated tau.
No mercury was found in any neurons of the locus
ceruleus of 6 individuals with autism (5 male, 1 female,
age range 16–48 years). Mercury was present in locus
ceruleus neurons in 7 of 11 (64 %) age-matched control
individuals who did not have autism, which is signifi-
cantly more than in individuals with autism. No increase
in numbers of locus ceruleus neurons containing hyper-
phosphorylated tau was detected in people with autism.
In conclusion, most people with autism have not been
exposed early in life to quantities of mercury large
enough to be found later in adult locus ceruleus neurons.
Human locus ceruleus neurons are sensitive indicators of
mercury exposure, and mercury appears to remain in
these neurons indefinitely, so these findings do not
support the hypothesis that mercury neurotoxicity plays a
role in autism.
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Introduction
Environmental toxins (i.e., toxicants) have long been
suspected to play a role in the pathogenesis of autism,
but there is still disagreement as to what toxicants, if
any, could be involved (Lyall et al. 2014). One
toxicant that has been repeatedly implicated in
autism is mercury (Kern et al. 2012; Mutter et al.
2005). Although some autism studies have reported
environmental exposures to mercury during early
life, and measured various biomarkers of mercury
exposure, no consensus as to the role of mercury in
autism has been reached. One area of research in this
field where data are notably lacking is in assessments
of toxic metals such as mercury in the brains of
people with autism.
The region of the human brain that takes up most
mercury is the locus ceruleus in the pons (Pamphlett and
Kum Jew 2013b), probably because these neurons
innervate most of the blood vessels in the brain and so
are exposed to circulating toxins (Pamphlett 2014).
Once mercury enters locus ceruleus neurons it appears
to remain there indefinitely (Pamphlett and Kum Jew
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2015), which suggests the locus ceruleus can act as a
indicator of past exposure to this toxic metal. Human
exposure to mercury appears to be quite common, since
43 out of 60 (72 %) adults without neurological or
psychiatric disorders have been shown to have mercury
within locus ceruleus neurons (Pamphlett and Kum Jew
2013a; 2015). A decrease of noradrenaline output from
locus ceruleus neurons has been postulated to underlie
some of the features of autism (Martchek et al. 2006;
Mehler and Purpura 2009), so it seems worthwhile to
look for the presence of mercury in the locus ceruleus in
people who have had autism.
A histochemical technique that can detect nano-
gram amounts of mercury in tissues is autometallog-
raphy (Danscher and Moller-Madsen 1985), so we
used this method to look for evidence of mercury in
locus ceruleus neurons in people with autism com-
pared to controls. We also looked for evidence of
damage to locus ceruleus neurons in autism by




7 lm paraffin sections of pons containing the locus
ceruleus were available from 6 individuals with autism
from the Oxford Brain Bank (5 male, 1 female, mean
age 27 years, age range 16–48 years). The diagnosis
of autism was made during life on Autism Diagnostic
Interview-Revised criteria. Causes of death were three
cases of sudden unexpected death in epilepsy and one
each of cystic fibrosis, glioblastoma multiforme, and
water intoxication. Control stained sections of pons
were available from 5 neurologically-normal controls
(3 male, 2 female, age range 26–47 years) and 6
patients with amyotrophic lateral sclerosis (5 male, 1
female, age range 38–49 years) from previous studies
of locus ceruleus neurons (Pamphlett and Kum Jew
2013a, 2015).
Autometallographic staining for mercury
Sections were stained with silver nitrate autometallog-
raphy, which under routine conditions stains the
sulphides or selenides of mercury, silver, and bis-
muth (Danscher and Moller-Madsen 1985; Danscher
et al. 2000). The silver-coated deposits of these metals
in tissues are seen histologically as black-staining
grains, and referred to as AMGHM (autometallography-
demonstrable heavy metals). Sections were placed in
physical developer containing gum arabic, citrate
buffer, hydroquinone and silver nitrate at 26 C for
80 min in the dark, then washed in sodium thiosulphate
to remove unbound silver. Sections were counterstained
with mercury-free haematoxylin and viewed under
bright-field microscopic illumination at 600 9 magni-
fication. A positive control section was included of
mouse spinal motor neurons that contained mercury
following intraperitoneal exposure to mercuric chlo-
ride (Pamphlett and Png 1998). The percentage of locus
ceruleus neurons containing AMGHM was calculated as
previously described (Pamphlett and Kum Jew 2015).
AT8 staining for hyperphosphorylated tau
Paraffin sections were treated with hydrogen peroxide
followed by normal horse serum and incubated in the
monoclonal antibody AT8 AntiHuman Phos PHF Tau
pSer202/Thr 205 (Thermo MN1020) at 1:1000 for
60 min at 37 C. Slides were incubated with Envision
Dual Link HRP and visualized with 3,3 diaminoben-
zidine tetrahydrochloride, then counterstained with
haematoxylin and viewed with bright-field microscopy.
Ethics
Sections of post mortem paraffin-embedded pons were
obtained after application to the UK Oxford Brain
Bank, which with approval from a research ethics
committee collects and distributes consented donated
brain tissue for research. No patient consent specifically
for this project was therefore applicable. The work was
carried out in accordance with the ethical standards of
the Human Ethics Review Committee (RPAH Zone) of
the Sydney Local Health District (X14-0029) and with
the Declaration of Helsinki as revised in 2000. The
authors declare they have no conflicts of interest.
Results
Autometallography
No AMGHM was seen in locus ceruleus neurons of any
of the six individuals with autism (Fig. 1a). In
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comparison with age-matched controls, using the
same AMG technique, two of five neurologically-
normal controls had locus ceruleus neurons containing
AMGHM (2 and 5 % of neurons respectively), as did
five of six amyotrophic lateral sclerosis patients (4, 5,
17, 22 and 32 % of neurons respectively) (Pamphlett
and Kum Jew 2013a) (Fig. 1b). The presence of
AMGHM in LC neurons of autism individuals was
significantly less than for combined age-matched
controls (Fisher’s exact two-sided p = 0.03).
AT8 for hyperphosphorylated tau
AT8 staining was seen in one neurite in the locus
ceruleus of one individual with autism (Fig. 1c), but in
none of the other five individuals with autism. No cell
bodies of locus ceruleus neurons of any autism
individual showed AT8 staining. In comparison, using
the same AT8 technique, in 12 individuals who had no
neurological or psychiatric conditions (7 male, 5
female, age range 51–59 years) AT8 staining was
present in locus ceruleus neurites in 3 individuals and
in neuronal cell bodies in 2 individuals (Pamphlett and
Kum Jew 2015).
Discussion
No mercury was detected in locus ceruleus neurons of
people with autism using a sensitive histochemical
technique that can show the presence of nanogram
amounts of mercury. This is despite the locus ceruleus
being the region of the human brain that takes up
circulating mercury most avidly, and the frequent
presence of mercury in these neurons in control
individuals. Furthermore, no signs of damage to the
bFig. 1 a Three locus ceruleus neurons in this individual with
autism contain yellow–brown neuromelanin pigment, but no
black grains of autometallographically-detectable mercury
(AMGHM). b One locus ceruleus neuron in this patient with
amyotrophic lateral sclerosis shows widespread (closed arrow),
and one scattered (open arrow), AMGHM; other neurons,
including a non-pigmented neuron (arrow-head) show no
AMGHM. a, b Autometallography and hematoxylin. c Staining
for hyperphosphorylated tau is seen in a locus ceruleus neurite
(asterisks) in this individual with autism, but not in the cell body
of an adjacent pigmented neuron. AT8 immunostaining and
hematoxylin. All bars 20 lm
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locus ceruleus was seen on hyperphosphorylated tau
immunostaining, beyond that expected for age. These
findings do not support the hypothesis that exposure to
mercury early in life is a risk factor for autism, or that
the locus ceruleus is damaged in autism.
The study has a number of limitations. (1) Numbers
of autism post mortem samples available for exami-
nation were limited, so it remains possible that a subset
of people with autism could have mercury in their
locus ceruleus neurons. Autism is seldom a life-
threatening disorder, so even brain banks that spe-
cialise in recruiting autism donors such as the one
accessed here have only limited numbers of brain
samples available for research. Nevertheless, statisti-
cally fewer people with autism had mercury in the
locus ceruleus neurons than age-matched controls. (2)
Trace amounts of mercury could have triggered an
autoimmune response (Mutter et al. 2005) which
destroyed the neurons that contained the mercury, so
they would not have survived to be examined. There is
however no evidence of a loss of locus ceruleus
neuronal in autism (Martchek et al. 2006). (3) Mer-
cury could transiently enter and then be cleared from
locus ceruleus neurons (a ‘‘hit-and-run’’ effect). This
seems unlikely, since neuromelanin binds heavy
metals (Double et al. 2008) and the pigment appears
already by the fifth month of gestation in locus
ceruleus neurons (Foley and Baxter 1958). Mercury
would therefore be expected to remain in these
neurons indefinitely.
More work is needed to find out if a range of toxic
element other than mercury could be present in the
brains of people with autism. Multiple elements within
cells can now be detected using synchrotron X-ray
fluorescence microprobe analysis (Aitken et al. 2010).
This technique could be used to look for a large
number of toxic elements within locus ceruleus
neurons, but this will depend on the availability of
sufficient numbers of frozen pons samples from people
with autism as well as controls.
In conclusion, our findings do not support the
hypothesis that exposure to mercury is a risk factor for
autism. The usual caveat of ‘‘absence of evidence is
not evidence of absence’’ needs however to be heeded,
and further efforts to analyse brain, and in particular
locus ceruleus, toxins in autism should be encouraged.
Acknowledgments Paraffin sections were obtained from the
Oxford Brain Bank, which is supported by the Medical Research
Council, Brains for Dementia Research, Alzheimer Society and
Alzheimer Research UK, Autistica UK and the National
Institute for Health Research Oxford Biomedical Research
Centre. The project was supported by the Aimee Stacey
Memorial and Ignacy Burnett Bequests.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unre-
stricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original
author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made.
References
Aitken JB, Carter EA, Eastgate H, Hackett MJ, Harris HH,
Levina A, Lee YC, Chen CI, Lai B, Vogt S, Lay PA (2010)
Biomedical applications of X-ray absorption and vibra-
tional spectroscopic microscopies in obtaining structural
information from complex systems. Radiat Phys Chem
79:176–184
Braak H, Del Tredici K (2011) The pathological process
underlying Alzheimer’s disease in individuals under thirty.
Acta Neuropathol 121:171–181
Danscher G, Moller-Madsen B (1985) Silver amplification of
mercury sulfide and selenide: a histochemical method for
light and electron microscopic localization of mercury in
tissue. J Histochem Cytochem 33:219–228
Danscher G, Stoltenberg M, Kemp K, Pamphlett R (2000)
Bismuth autometallography: protocol, specificity, and
differentiation. J Histochem Cytochem 48:1503–1510
Double KL, Dedov VN, Fedorow H, Kettle E, Halliday GM,
Garner B, Brunk UT (2008) The comparative biology of
neuromelanin and lipofuscin in the human brain. Cell Mol
Life Sci 65:1669–1682
Foley JM, Baxter D (1958) On the nature of pigment granules in
the cells of the locus coeruleus and substantia nigra.
J Neuropathol Exp Neurol 17:586–598
Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR
(2012) Evidence of parallels between mercury intoxication
and the brain pathology in autism. Acta Neurobiol Exp
72:113–153
Lyall K, Schmidt RJ, Hertz-Picciotto L (2014) Maternal life-
style and environmental risk factors for autism spectrum
disorders. Int J Epidemiol 43:443–464
Martchek M, Thevarkunnel S, Bauman M, Blatt G, Kemper I
(2006) Lack of evidence of neuropathology in the locus
coeruleus in autism. Acta Neuropathol 111:497–499
Mehler MF, Purpura DP (2009) Autism, fever, epigenetics and
the locus coeruleus. Brain Res Rev 59:388–392
Mutter J, Naumann J, Schneider R, Walach H, Haley B (2005)
Mercury and autism: accelerating evidence? Neuroen-
docrinol Lett 26:439–446
Pamphlett R (2014) Uptake of environmental toxicants by the
locus ceruleus: a potential trigger for neurodegenerative,
demyelinating and psychiatric disorders. Med Hypotheses
82:97–104
174 Biometals (2016) 29:171–175
123
Pamphlett R, Kum Jew S (2013a) Heavy metals in locus cer-
uleus and motor neurons in motor neuron disease. Acta
Neuropathol Commun 1:81
Pamphlett R, Kum Jew S (2013b) Uptake of inorganic mercury
by human locus ceruleus and corticomotor neurons:
implications for amyotrophic lateral sclerosis. Acta Neu-
ropathol Commun 1:13
Pamphlett R, Kum Jew S (2015) Different populations of
human locus ceruleus neurons contain heavy metals or
hyperphosphorylated tau: implications for amyloid-beta and
tau pathology in Alzheimer’s disease. J Alzheimers Dis
45:437–447
Pamphlett R, Png FY (1998) Shrinkage of motor axons fol-
lowing systemic exposure to inorganic mercury. J Neu-
ropathol Exp Neurol 57:360–366
Biometals (2016) 29:171–175 175
123
